Medical Science Liaison, Neuropsychiatry at Bristol-Myers Squibb

United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Proficiency in using available scientific resources and presentations
  • Ability to effectively present information to TLs/HCPs and respond to questions, ensuring medical accuracy and compliance with local procedures, ethical, and legal guidelines
  • Continuous updating of knowledge in treatment strategies, products, unmet medical needs, clinical trials, health economics outcomes research, and scientific activities
  • Understanding of the competitive landscape and evolving healthcare models

Responsibilities

  • Develop and maintain relationships with academic and community research thought leaders, appropriate HCPs, and access stakeholders within a given geography to answer scientific, unsolicited product, and HEOR-related questions using various channels (1:1, group presentations, remote, etc.)
  • Actively assess the medical landscape by meeting with TLs/HCPs/Access Stakeholders to understand their needs and expertise
  • Identify opportunities to partner with HCPs on disease state initiatives, collaborative research projects, and investigator-sponsored research (ISR) aligned with BMS strategic objectives
  • Attend medical congresses and local/regional meetings; collect and provide meaningful medical insights to medical and commercial organizations to support strategy development and business decisions
  • Develop geography-specific Field Medical and TL Interaction plans based on therapeutic area objectives and TLs needs
  • Adopt institution/account planning approach and contribute to cross-functional institution/account plans
  • Contribute to development and delivery of scientifically meaningful medical programs/projects in line with the local Medical and Field Medical plan
  • Provide medical support by establishing customer-centric, compliant collaborations

Skills

Medical Science Liaison
Neuropsychiatry
Thought Leader Engagement
Healthcare Providers
Scientific Exchange
Medical Education
Data Generation
Insight Generation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI